Shares of Neuren Pharmaceuticals (ASX:NEU) rose almost 1% in early trading on Wednesday, while those of CSL (ASX:CSL) were marginally lower, following US President Donald Trump's remarks on tariffs on the pharmaceutical industry on Tuesday.
Trump threatened to impose up to 200% tariffs on pharmaceuticals imported into the US "very soon," adding that he will "give people about a year, year and a half," CNBC reported.